Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
43.54%
median of 609 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Estrella Immunopharma, Inc.
Market Cap
$19.96M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$20.21M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$19.86M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$18.54M
Gross Margin
10.27%
TTM Avg
10.01%
3Y Avg
10.00%
5Y Avg
11.56%
Market Cap
$18.70M
Gross Margin
43.54%
TTM Avg
69.65%
3Y Avg
34.83%
5Y Avg
-433.64%
Market Cap
$22.43M
Gross Margin
63.95%
TTM Avg
66.50%
3Y Avg
67.57%
5Y Avg
61.13%
Market Cap
$17.15M
Gross Margin
-334.26%
TTM Avg
-117.13%
3Y Avg
-347.18%
5Y Avg
-222.70%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | $19.96M | 0.00% | 0.00% | 0.00% | 0.00% |
| Modular Medical, Inc. (MODD)vs › | $20.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cosmos Health Inc. (COSM)vs › | $18.54M | 10.27% | 10.01% | 10.00% | 11.56% |
| NextCure, Inc. (NXTC)vs › | $18.82M | 0.00% | 0.00% | 0.00% | -18.00% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.70M | 43.54% | 69.65% | 34.83% | -433.64% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.43M | 63.95% | 66.50% | 67.57% | 61.13% |
| LeonaBio, Inc. (LONA)vs › | $22.64M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lipocine Inc. (LPCN)vs › | $17.15M | -334.26% | -117.13% | -347.18% | -222.70% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.09M | 0.00% | -52.16% | -139.89% | -776.52% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-02-28 | 0.00% |
